Rossari Biotech Declines 4.01% Amid Technical Downgrade and Flat Financials
2026-11-21 12:02:54Key Events This Week 16 Nov: Upgrade to Hold rating amid technical improvement 17 Nov: Mixed technical momentum with modest price gain 18 Nov: Continued technical uncertainty despite slight gains 19 Nov: Downgrade to Sell as technicals weaken and financials disappoint 20 Nov: Bearish momentum confirmed with further price decline Week OpenRs.438.10</div...
Read More
Rossari Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-11-20 08:04:42Rossari Biotech Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 19 Nov 2026. The stock’s recent price action and technical indicators signal a bearish trend, reflecting growing investor caution amid broader market dynamics.
Read More
Rossari Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-11-18 08:05:26Rossari Biotech Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 1.56%, the stock’s technical indicators present a complex picture, reflecting mixed signals that investors should carefully analyse amid broader market trends.
Read More
Rossari Biotech Upgraded to Hold as Technicals Improve Amid Mixed Financials
2026-11-16 08:47:58Rossari Biotech Ltd, a specialty chemicals company, has seen its investment rating upgraded from Sell to Hold as of 13 Nov 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite ongoing challenges in long-term growth and market performance.
Read More
Rossari Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-11-16 08:04:11Rossari Biotech Ltd has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 2.11% gain on the day to close at ₹438.10, the stock’s longer-term technical signals remain mixed, underscoring the need for cautious analysis amid volatile market conditions.
Read More
Rossari Biotech Ltd is Rated Hold by MarketsMOJO
2026-11-15 10:10:41Rossari Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 November 2026, providing investors with the latest insights into its performance and outlook.
Read More
Rossari Biotech Ltd is Rated Sell
2026-11-04 10:11:29Rossari Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Rossari Biotech Ltd is Rated Sell
2026-10-24 10:10:39Rossari Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Rossari Biotech Ltd is Rated Sell
2026-10-13 10:10:37Rossari Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
22-Oct-2026 | Source : BSEIntimation of Transcript of Q2 & H1 FY27 for the Earnings Conference Call held on October 19 2026
Announcement under Regulation 30 (LODR)-Investor Presentation
19-Oct-2026 | Source : BSEIntimation of Q2 & H1 FY27- Earnings Presentation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
19-Oct-2026 | Source : BSEAudio recording of Earnings Conference Call for Q2 & H1 FY 27.
Corporate Actions
No Upcoming Board Meetings
Rossari Biotech Ltd has declared 25% dividend, ex-date: 10 Jul 26
No Splits history available
No Bonus history available
No Rights history available